Effects of transmembrane region variability on cell surface expression and allorecognition of HLA-DP3

Human Immunology

Volumn 74, Issue 8, 2013, Pages 970-977

  Crivello, Pietro ^a   Lauterbach, Nina ^b   Zito, Laura ^a   Sizzano, Federico ^a   Toffalori, Cristina ^a   Marcon, Jessica ^a   Curci, Laura ^a   Mulder, Arend ^c   Wieten, Lotte ^b   Zino, Elisabetta ^a   Voorter, Christien E M ^b   Tilanus, Marcel G J ^b   Fleischhauer, Katharina ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 ANTIGEN; GAMMA INTERFERON; HLA D ANTIGEN; HLA DP3 ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; UNCLASSIFIED DRUG;

ALGORITHM; ALLOIMMUNITY; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CELL SURFACE; CYTOKINE PRODUCTION; CYTOTOXICITY; DAUDI CELL; GENE FREQUENCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IN VIVO STUDY; MONOCYTE; MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN POLYMORPHISM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ΔLNGFR; Γ-IFN; BLCL; EPSTEIN-BARR VIRUS TRANSFORMED B LYMPHOBLASTOID CELL LINES; GAMMA INTERFERON; GRAFT VERSUS HOST DISEASE; GVHD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HPGK; HSCT; HUMAN PHOSPHOGLYCERATE KINASE; LENTIVIRAL EXPRESSION VECTOR; LV; MEDIAN FLUORESCENCE INTENSITY; MESF; MFI; MIXED LYMPHOCYTE REACTION; MLR; MOLECULES OF EQUIVALENT SOLUBLE FLUOROCHROME; PBMC; PCR-SEQUENCE SPECIFIC PRIMING; PCR-SSP; PERIPHERAL BLOOD MONONUCLEAR CELLS; R; RESPONDER DONOR; S; STIMULATOR DONOR; T CELL EPITOPE; TCE; TM; TRANSMEMBRANE; TRUNCATED FORM OF THE HUMAN LOW AFFINITY NERVE GROWTH FACTOR RECEPTOR; VOLUNTEER UNRELATED DONORS; VUD;

ALLELES; B-LYMPHOCYTES; CELL LINE, TUMOR; CELL MEMBRANE; GENE EXPRESSION; GENE FREQUENCY; GENETIC VARIATION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA-DP BETA-CHAINS; HUMANS; IMMUNOPHENOTYPING; T-LYMPHOCYTE SUBSETS; UNRELATED DONORS;

EID: 84879879934     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.04.014     Document Type: Article

References (33)

1. Little A.M., Parham P. Polymorphism and evolution of HLA class I and II genes and molecules. Rev Immunogenet 1999, 1(1):105-123.
2. Klein J., Sato A. The HLA system. First of two parts. N Engl J Med 2000, 343(10):702-709.
3. Ferrara G.B., Bacigalupo A., Lamparelli T., Lanino E., Delfino L., Morabito A., et al. Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood 2001, 98(10):3150-3155.
4. Flomenberg N., Baxter-Lowe L.A., Confer D., Fernandez-Vina M., Filipovich A., Horowitz M., et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004, 104(7):1923-1930.
5. Lee S.J., Klein J., Haagenson M., Baxter-Lowe L.A., Confer D.L., Eapen M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110(13):4576-4583.
6. Petersdorf E.W., Malkki M., Hsu K., Bardy P., Cesbron A., Dickinson A., et al. 16th IHIW: international histocompatibility working group in hematopoietic cell transplantation. Int J Immunogenet 2013, 40(1):2-10.
7. Nunes E., Heslop H., Fernandez-Vina M., Taves C., Wagenknecht D.R., Eisenbrey A.B., et al. Definitions of histocompatibility typing terms. Blood 2011, 118(23):e180-e183.
8. Reinders J., Rozemuller E.H., van Gent R., Arts-Hilkes Y.H., van den Tweel J.G., Tilanus M.G. Extended HLA-DPB1 polymorphism: an RNA approach for HLA-DPB1 typing. Immunogenetics 2005, 57(10):790-794.
9. Lauterbach N., Voorter C.E., Stallinga C.M., Groeneweg M., Wieten L., Tilanus M.G. Full-length HLA-DPB1 diversity in multiple alleles of individuals from Caucasian, Black, or Oriental origin. Tissue Antigens 2012, 79(3):165-173.
10. Robinson J., Mistry K., McWilliam H., Lopez R., Parham P., Marsh S.G. The IMGT/HLA database. Nucleic Acids Res 2011, 39:D1171-D1176.
11. Magor K.E., Taylor E.J., Shen S.Y., Martinez-Naves E., Valiante N.M., Wells R.S., et al. Natural inactivation of a common HLA allele (A*2402) has occurred on at least three separate occasions. J Immunol 1997, 158(11):5242-5250.
12. Elsner H.A., Blasczyk R. Immunogenetics of HLA null alleles: implications for blood stem cell transplantation. Tissue Antigens 2004, 64(6):687-695.
13. Dunn P.P., Hammond L., Coates E., Street J., Griner L., Darke C. A "silent" nucleotide substitution in exon 4 is responsible for the "alternative expression" of HLA-A*01:01:38L through aberrant splicing. Hum Immunol 2011, 72(9):717-722.
14. Bade-Doeding C., Cano P., Huyton T., Badrinath S., Eiz-Vesper B., Hiller O., et al. Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B*44:02P. Hum Immunol 2011, 72(11):1039-1044.
15. Xiao Y., Lazaro A.M., Masaberg C., Haagenson M., Vierra-Green C., Spellman S., et al. Evaluating the potential impact of mismatches outside the antigen recognition site in unrelated hematopoietic stem cell transplantation: HLA-DRB1*1454 and DRB1*140101. Tissue Antigens 2009, 73(6):595-598.
16. Pasi A., Crocchiolo R., Bontempelli M., Carcassi C., Carella G., Crespiatico L., et al. The conundrum of HLA-DRB1*14:01/*14:54 and HLA-DRB3*02:01/*02:02 mismatches in unrelated hematopoietic SCT. Bone Marrow Transplant 2011, 46(7):916-922.
17. Zino E., Vago L., Di Terlizzi S., Mazzi B., Zito L., Sironi E., et al. Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007, 13(9):1031-1040.
18. Hollenbach J.A., Madbouly A., Gragert L., Vierra-Green C., Flesch S., Spellman S., et al. A combined DPA1 approximately DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer. Immunogenetics 2012, 64(8):559-569.
19. Zino E., Frumento G., Marktel S., Sormani M.P., Ficara F., Di Terlizzi S., et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood 2004, 103(4):1417-1424.
20. Crocchiolo R., Zino E., Vago L., Oneto R., Bruno B., Pollichieni S., et al. Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. Blood 2009, 114(7):1437-1444.
21. Fleischhauer K., Shaw B.E., Gooley T., Malkki M., Bardy P., Bignon J.D., et al. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. Lancet Oncol 2012, 13(4):366-374.
22. Fleischhauer K., Zino E., Mazzi B., Sironi E., Servida P., Zappone E., et al. Peripheral blood stem cell allograft rejection mediated by CD4(+) T lymphocytes recognizing a single mismatch at HLA-DP beta 1*0901. Blood 2001, 98(4):1122-1126.
23. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003, 281(1-2):65-78.
24. Wolfl M., Kuball J., Ho W.Y., Nguyen H., Manley T.J., Bleakley M., et al. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood 2007, 110(1):201-210.
25. Schwartz A., Gaigalas A.K., Wang L., Marti G.E., Vogt R.F., Fernandez-Repollet E. Formalization of the MESF unit of fluorescence intensity. Cytometry B Clin Cytom 2004, 57(1):1-6.
26. Amendola M., Venneri M.A., Biffi A., Vigna E., Naldini L. Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. Nat Biotechnol 2005, 23(1):108-116.
27. Gonwa T.A., Frost J.P., Karr R.W. All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma. J Immunol 1986, 137(2):519-524.
28. Vinay D.S., Kwon B.S. Immunotherapy of cancer with 4-1BB. Mol Cancer Ther 2012, 11(5):1062-1070.
29. Suni M.A., Maino V.C., Maecker H.T. Ex vivo analysis of T-cell function. Curr Opin Immunol 2005, 17(4):434-440.
30. Arroyo J., Diez-Orejas R., Alvarez A.M., Shaw S., Sanchez-Perez M. Molecular analysis of an HLA-DP mutant cell line selected for its resistance to killing by HLA-DPw2-specific T-cell clones. Immunogenetics 1994, 39(1):40-47.
31. Weber D.A., Dao C.T., Jun J., Wigal J.L., Jensen P.E. Transmembrane domain-mediated colocalization of HLA-DM and HLA-DR is required for optimal HLA-DM catalytic activity. J Immunol 2001, 167(9):5167-5174.
32. Jahnke M., Trowsdale J., Kelly A.P. Structural requirements for recognition of major histocompatibility complex class II by membrane-associated RING-CH (MARCH) protein E3 ligases. J Biol Chem 2012, 287(34):28779-28789.
33. Davis D.M., Mandelboim O., Luque I., Baba E., Boyson J., Strominger J.L. The transmembrane sequence of human histocompatibility leukocyte antigen (HLA)-C as a determinant in inhibition of a subset of natural killer cells. J Exp Med 1999, 189(8):1265-1274.